LIR Life Sciences Corp.
BBCMD
$0.65
$0.0711.52%
OTC PK
| 07/31/2025 | 07/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 7.30K | -- | |||
| Gross Profit | -7.30K | -- | |||
| SG&A Expenses | 93.80K | 33.20K | |||
| Depreciation & Amortization | 800.00 | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 101.90K | 33.20K | |||
| Operating Income | -101.90K | -33.20K | |||
| Income Before Tax | -102.00K | -33.20K | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -102.00K | -33.20K | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -102.00K | -33.20K | |||
| EBIT | -101.90K | -33.20K | |||
| EBITDA | -101.10K | -- | |||
| EPS Basic | -0.01 | -0.66 | |||
| Normalized Basic EPS | 0.00 | -0.41 | |||
| EPS Diluted | -0.01 | -0.66 | |||
| Normalized Diluted EPS | 0.00 | -0.41 | |||
| Average Basic Shares Outstanding | 19.00M | 50.00K | |||
| Average Diluted Shares Outstanding | 19.00M | 50.00K | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||